PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
PALLITE® is a designer and manufacturer of award-winning, strong, lightweight, patented, fully recyclable honeycomb paper crates, pallets and warehouse storage solutions for brands such as Kellogg's, Morrisons, and DHL. The company has 10 IP-registered designs across North America and Europe. In 2018, the company's sales grew by 58 %, and in the last two months, the sales were up by 33% in the previous quarter. PALLITE®'s goal is to reduce the weight of transit packaging by up to 83% and consequently reduce carbon emissions by up to 37%. Its goal is to give huge profitable growth potential in the UK and all over the world.
days to go:
Expired
investment:
£1,197,760
Alphagreen is Europe's largest online marketplace for Cannabidiol (CBD) healthcare products listing over 150 brands and more than 2,500 products on its portal. It claims that it is backed by high-profile cannabis investors like Enexis, West Creek Investments, and others. It aspires to become the leader in the CBD market that is expected to be worth over £900 million in 2025 in the UK alone. Alphagreen aspires to build a trusted ecosystem for customers with Sleep, Pain and Anxiety problems, enable them to access alternative healthcare, and distribute medical cannabis from Q3 of 2021. The company has featured in Forbes, Business Insider, Prohibition Partners, The Financial Times, and The Grocer. It will use 31% of the investment for sales and marketing, 25% for team expansion, 16% for general corporate affairs, 15% for international expansion, and 13% for technology up-gradation.
days to go:
Expired
investment:
£2,039,375
JOHNNY'S is an ethical, vegan, and sex-positive subscription condom brand. The company aims to deliver its products on a subscription basis, following in the footsteps of Direct-To-Consumer (DTC) health disruptors like Harry's and Dollar Shave Club. It aims to become a contender in the global condom market that is set to be worth $15 Billion by 2026 and enter the lubricant and sex toy market later in 2021. The company has also pledged to give a condom to HIV/STI/NHS clinics for each condom sold. It will use the investment for a PR launch, social media advertising, stock purchase, and attract talent to help the business hit its growth targets.
days to go:
Expired
investment:
£182,281
Archie Foal is a company that makes clothes, that are designed to look good and last for many years. The staff have experience from big brands such as Ralph Lauren and Versace. They started off selling socks in stores such as Selfridges, Harrods and Fenwicks. Their clothing line has now grown to include shirting, outerwear, knitwear and a whole range of accessories. They are looking for investment to open two new London stores and develop their Ecommerce, marketing and whole sale strategies.
days to go:
Expired
investment:
£346,010
Hemspan states that it designs bio-based building systems and products for construction by combining modern methods, technology and hemp to produce net-zero carbon solutions. The company argues that every time an average house is built, the CO2 emitted by the manufacture, transport and assembly of the materials used is around 50 to 60 tonnes. Hemspan says that one hectare of UK-grown industrial hemp can absorb 11 tonnes of CO2 each year with regeneratively farmed hemp capable of sequestering a further 6 tonnes per hectare of CO2 into the soil each year. Hemspan intends to activate significant demand for hemp farming in the UK and develop processing technologies to reduce reliance on imports and enable large scale manufacturing of bio-based cladding and insulation products that spin out of R&D programmes. It asserts that the global industrial hemp market is expected to grow at 25% CAGR reaching US$ 27 billion by 2028. It aims to be a contender in this segment.
days to go:
Expired
investment:
£200,000
